BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 68 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 194 | -98.2% | 0.00% | – |
| Q1 2022 | $30,000 | -47.4% | 10,694 | 0.0% | 0.00% | – |
| Q4 2021 | $57,000 | -59.6% | 10,694 | -36.0% | 0.00% | – |
| Q3 2021 | $141,000 | -30.5% | 16,722 | +0.4% | 0.00% | – |
| Q2 2021 | $203,000 | -49.2% | 16,648 | +0.9% | 0.00% | – |
| Q1 2021 | $400,000 | -24.4% | 16,500 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $529,000 | +31.6% | 16,500 | +24.1% | 0.00% | – |
| Q3 2020 | $402,000 | -12.6% | 13,300 | +22.0% | 0.00% | -100.0% |
| Q2 2020 | $460,000 | – | 10,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |